2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow carmoterol: new trials by email Literature Review of carmoterol trials Research Report on carmoterol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI (Carmoterol) in Patients With COPD carmoterol (CHF 4226), placebo, salmeterol - Chronic Obstructive Pulmonary Disease | Phase 2 | Completed | Chiesi Farmaceutici S.p.A. | 57 | 2008-04-01 | 2010-08-27 |
| Dose Finding Study of CHF 4226 for Treating Patients With COPD carmoterol (CHF 4226), salmeterol, placebo - Chronic Obstructive Pulmonary Disease | Phase 2 | Completed | Chiesi Farmaceutici S.p.A. | 278 | 2006-10-01 | 2017-04-11 |
Pulmonary Disease, Chronic Obstructive (2)
Chiesi Farmaceutici S.p.A. (2)
United States (2) · Czechia (1) · Germany (1) · Poland (1) · Romania (1) · South Africa (1)
Barry Make, MD (1) · Donald P. Tashkin, MD (1) · Steven E Linberg, Ph.D. (1) · Steven E. Linberg, PhD (1)